Centers | ||
|
|
|
Chulalongkorn University Drug Discovery and Drug Development Research Center (Chula4DR) | Centre for Collaborative Drug Research | Drug Discovery Core |
Chulalongkorn
Drug Discovery and Drug Development Research Center (Chula4DR) was
established in 2017, with the aim to facilitate advancement of academic
drug discovery and drug development research by leveraging innovations
and sciences... Read more |
The Centre for Collaborative Drug Research is a multidisciplinary initiative bringing together the Faculties of Medicine and Pharmacy at the University of Toronto, Canadas leading academic institution and largest research entity, and the Centre... |
The Drug Discovery Core at the University of Utah is an established Service/Recharge center that provides compound collections for screening by University of Utah Faculty. Our mission is to provide customers low-cost and efficient access to chemical... |
Partnerships |
Events |
Jobs |
Sanofi and MIT Form New Partnership to Foster Industry - Academic CollaborationSanofi and MIT's Center for Biomedical Innovation has established a new partnership to foster basic and applied research and develop solutions to address unmet clinical needs. Sanofi will be providing funding to support specific research projects... View all Evotec and Yale University form Open Innovation AllianceEvotec and Yale intend to leverage first rate science performed at Yale University together with Evotec's drug discovery infrastructure and expertise into highly innovative discovery approaches in diseases of high unmet medical need. Initially,... View all Johns Hopkins BSi Licenses GCPII Assets from EisaiJohns Hopkins Brain Science Institute ("BSi") has taken a non-exclusive license from Eisai to develop new compounds related to Glutamate Carboxypeptidase II (GCP-II) technology. The new compounds developed under this license will be targeted... View all |
No EVENTS for listing |
No Job Posts |
